Electrocardiographic effects of HBI-3000 (sulcardine sulfate), a new drug for termination of atrial fibrillation

ABSTRACT:

SUBMITTER: Mason J 

PROVIDER: S-EPMC12925892 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature